Found: 14
Select item for more details and to access through your institution.
Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 8, p. 1334, doi. 10.3390/medicina60081334
- By:
- Publication type:
- Article
Impact of post‐progression survival in second‐line treatment with molecular target agents for unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 403, doi. 10.1111/hepr.13986
- By:
- Publication type:
- Article
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 62, doi. 10.1111/hepr.13572
- By:
- Publication type:
- Article
A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment.
- Published in:
- Internal Medicine, 2022, v. 61, n. 7, p. 951, doi. 10.2169/internalmedicine.7589-21
- By:
- Publication type:
- Article
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2024, v. 102, n. 2, p. 131, doi. 10.1159/000533952
- By:
- Publication type:
- Article
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis.
- Published in:
- Oncology, 2023, v. 101, n. 2, p. 134, doi. 10.1159/000526976
- By:
- Publication type:
- Article
Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 6, p. 320, doi. 10.1159/000523850
- By:
- Publication type:
- Article
Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage.
- Published in:
- Oncology, 2022, v. 100, n. 1, p. 31, doi. 10.1159/000519995
- By:
- Publication type:
- Article
Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 611, doi. 10.1159/000516565
- By:
- Publication type:
- Article
Potential and Clinical Significance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 169, doi. 10.1159/000510754
- By:
- Publication type:
- Article
A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
The useful predictors of zinc deficiency for the management of chronic liver disease.
- Published in:
- Journal of Gastroenterology, 2022, v. 57, n. 4, p. 322, doi. 10.1007/s00535-022-01852-0
- By:
- Publication type:
- Article
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02829-w
- By:
- Publication type:
- Article